Evaluation of serum Midkine as a Diagnostic Marker for Hepatocellular Carcinoma in Hepatitis C virus Patients with Liver Cirrhosis - Egyptian Knowledge Bank - troweb

188497

Evaluation of serum Midkine as a Diagnostic Marker for Hepatocellular Carcinoma in Hepatitis C virus Patients with Liver Cirrhosis

Article

Last updated: 01 Jan 2025

Overview Similar Items

Article

Evaluation of Serum Midkine as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients

Article

Evaluation of serum Midkine as a novel biomarker for the diagnosis of hepatocellular carcinoma

Article

Role of Serum Midkine Level as a Diagnostic Biomarker for Very Early and Early Hepatocellular Carcinoma

Article

VALUE OF SERUM MIDKINE LEVEL IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA

Article

Clinical Significance of Serum Midkine Level as a Biomarker in Diagnosis of Hepatocellular Carcinoma

Article

Value of Midkine as a Diagnostic Serum Marker in Hepatocellular Carcinoma

Article

MOLECULAR EVALUATION OF MIDIKINE (MDK) AS A POTENTIAL BIOMARKER TODETECT HEPATOCELLULAR CARCINOMA

Article

Serum Lactadherin as a Diagnostic Biomarker in Hepatitis C Virus Cirrhotic Patients with and without Hepatocellular Carcinoma

Article

Serum MiRNA-122 as a Diagnostic Marker in HCV Related Liver Cirrhosis

Article

Evaluation of Cytoskeleton-Linking Membrane Protein 63 as a Serum Marker for the Early Detection of Hepatocellular Carcinoma